Your browser doesn't support javascript.
loading
Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial.
Burke, G A Amos; Vinti, Luciana; Kabickova, Edita; Beishuizen, Auke; Tacyildiz, Nurdan; Uyttebroeck, Anne; Kang, Hyoung Jin; Luisi, Flavio; Minard-Colin, Véronique; Burkhardt, Birgit; Tamegnon, Monelle; Sun, Steven; Curtis, Madeliene; Deshpande, Sanjay; Nottage, Kerri; Howes, Angela; Srinivasan, Srimathi; Bhojwani, Deepa; Norris, Robin; Cairo, Mitchell.
Affiliation
  • Burke GAA; Department of Paediatric Haematology, Oncology and Palliative Care, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom.
  • Vinti L; Department of Pediatric Hematology/Oncology and Cell and Gene Therapy, Ospedale Pediatrico Bambino Gesù, Rome, Italy.
  • Kabickova E; Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Beishuizen A; Department of Hemato-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Tacyildiz N; Department of Pediatric Hematology/Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Uyttebroeck A; Department of Pediatric Hematology and Oncology, Ankara University Cebeci Hospital, Ankara, Turkey.
  • Kang HJ; Department of Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Luisi F; Department of Oncology, KU Leuven, Leuven, Belgium.
  • Minard-Colin V; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Wide River Institute of Immunology, Seoul National University Children's Hospital, Seoul, South Korea.
  • Burkhardt B; Pediatric Oncology Institute, GRAACC, São Paulo, Brazil.
  • Tamegnon M; Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Sun S; Pediatric Hematology and Oncology, University Hospital Münster, Münster, Germany.
  • Curtis M; Clinical Oncology, Janssen Research & Development, Raritan, NJ.
  • Deshpande S; Clinical Biostats, Janssen Research & Development, Raritan, NJ.
  • Nottage K; Clinical Oncology, Janssen Research & Development, High Wycombe, United Kingdom.
  • Howes A; Clinical Oncology, Janssen Research & Development, Raritan, NJ.
  • Srinivasan S; Clinical Oncology, Janssen Research & Development, Raritan, NJ.
  • Bhojwani D; Clinical Oncology, Janssen Research & Development, High Wycombe, United Kingdom.
  • Norris R; Oncology Translational Research, Janssen Research & Development, Lower Gwynedd Township, PA.
  • Cairo M; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA.
Blood Adv ; 7(4): 602-610, 2023 02 28.
Article in En | MEDLINE | ID: mdl-36541957
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Ifosfamide Type of study: Clinical_trials Limits: Adolescent / Adult / Child / Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Ifosfamide Type of study: Clinical_trials Limits: Adolescent / Adult / Child / Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article Affiliation country: